168 related articles for article (PubMed ID: 22281875)
1. Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab.
Giannecchini S; Clausi V; Vultaggio A; Macera L; Maggi F; Martelli F; Azzi A; Maggi E; Matucci A
J Neurovirol; 2012 Feb; 18(1):55-61. PubMed ID: 22281875
[TBL] [Abstract][Full Text] [Related]
2. Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab.
Bellizzi A; Anzivino E; Ferrari F; Di Nardo G; Colosimo MT; Fioriti D; Mischitelli M; Chiarini F; Cucchiara S; Pietropaolo V
J Neurovirol; 2011 Aug; 17(4):303-13. PubMed ID: 21547609
[TBL] [Abstract][Full Text] [Related]
3. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.
Bellizzi A; Nardis C; Anzivino E; Rodìo D; Fioriti D; Mischitelli M; Chiarini F; Pietropaolo V
J Neurovirol; 2012 Feb; 18(1):1-11. PubMed ID: 22290500
[TBL] [Abstract][Full Text] [Related]
4. Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.
Bellizzi A; Anzivino E; Rodio DM; Cioccolo S; Scrivo R; Morreale M; Pontecorvo S; Ferrari F; Di Nardo G; Nencioni L; Carluccio S; Valesini G; Francia A; Cucchiara S; Palamara AT; Pietropaolo V
Virol J; 2013 Sep; 10():298. PubMed ID: 24079660
[TBL] [Abstract][Full Text] [Related]
5. Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation.
Tan CS; Broge TA; Ngo L; Gheuens S; Viscidi R; Bord E; Rosenblatt J; Wong M; Avigan D; Koralnik IJ
Biol Blood Marrow Transplant; 2014 Jul; 20(7):992-9. PubMed ID: 24680976
[TBL] [Abstract][Full Text] [Related]
6. Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate.
Gosert R; Kardas P; Major EO; Hirsch HH
J Virol; 2010 Oct; 84(20):10448-56. PubMed ID: 20686041
[TBL] [Abstract][Full Text] [Related]
7. Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment.
Prezioso C; Grimaldi A; Landi D; Nicoletti CG; Brazzini G; Piacentini F; Passerini S; Limongi D; Ciotti M; Palamara AT; Marfia GA; Pietropaolo V
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578264
[TBL] [Abstract][Full Text] [Related]
8. JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab.
Uleri E; Ibba G; Piu C; Caocci M; Leoni S; Arru G; Serra C; Sechi G; Dolei A
J Neurovirol; 2017 Apr; 23(2):226-238. PubMed ID: 27812788
[TBL] [Abstract][Full Text] [Related]
9. Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy.
Wollebo HS; Safak M; Del Valle L; Khalili K; White MK
J Neuroimmunol; 2011 Apr; 233(1-2):46-53. PubMed ID: 21185609
[TBL] [Abstract][Full Text] [Related]
10. Human polyomavirus JC latency and reactivation status in blood of HIV-1-positive immunocompromised patients with and without progressive multifocal leukoencephalopathy.
Andréoletti L; Dubois V; Lescieux A; Dewilde A; Bocket L; Fleury HJ; Wattré P
AIDS; 1999 Aug; 13(12):1469-75. PubMed ID: 10465069
[TBL] [Abstract][Full Text] [Related]
11. Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.
Reid CE; Li H; Sur G; Carmillo P; Bushnell S; Tizard R; McAuliffe M; Tonkin C; Simon K; Goelz S; Cinque P; Gorelik L; Carulli JP
J Infect Dis; 2011 Jul; 204(2):237-44. PubMed ID: 21673034
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic reactivation of JC virus in patients treated with natalizumab.
Chen Y; Bord E; Tompkins T; Miller J; Tan CS; Kinkel RP; Stein MC; Viscidi RP; Ngo LH; Koralnik IJ
N Engl J Med; 2009 Sep; 361(11):1067-74. PubMed ID: 19741227
[TBL] [Abstract][Full Text] [Related]
13. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy.
Koralnik IJ; Boden D; Mai VX; Lord CI; Letvin NL
Neurology; 1999 Jan; 52(2):253-60. PubMed ID: 9932940
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic reactivation of JC virus in patients treated with natalizumab.
Warnke C; Adams O; Kieseier BC
N Engl J Med; 2009 Dec; 361(25):2489; author reply 2489-90. PubMed ID: 20050216
[No Abstract] [Full Text] [Related]
15. Analysis of variability of urinary excreted JC virus strains in patients infected with HIV and healthy donors.
Karalic D; Lazarevic I; Banko A; Cupic M; Jevtovic D; Jovanovic T
J Neurovirol; 2018 Jun; 24(3):305-313. PubMed ID: 29243131
[TBL] [Abstract][Full Text] [Related]
16. Infliximab and the risk of latent viruses reactivation in active Crohn's disease.
Lavagna A; Bergallo M; Daperno M; Sostegni R; Costa C; Leto R; Crocellà L; Molinaro G; Rocca R; Cavallo R; Pera A
Inflamm Bowel Dis; 2007 Jul; 13(7):896-902. PubMed ID: 17345605
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of human polyomavirus JC in patients affected by psoriasis vulgaris and psoriatic arthritis and treated with biological drugs: preliminary results.
Nardis C; Anzivino E; Bellizzi A; Rodio DM; De Pità O; Chiarini F; Pietropaolo V
J Cell Physiol; 2012 Dec; 227(12):3796-802. PubMed ID: 22422468
[TBL] [Abstract][Full Text] [Related]
18. JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus.
Zingaropoli MA; Iannetta M; Pontecorvo S; Anzivino E; Prezioso C; Rodio DM; Morreale M; D'Abramo A; Oliva A; Lichtner M; Cortese A; Frontoni M; Pietropaolo V; Francia A; Mastroianni CM; Vullo V; Ciardi MR
Biomed Res Int; 2018; 2018():5297980. PubMed ID: 29682547
[TBL] [Abstract][Full Text] [Related]
19. Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment.
Pietropaolo V; Bellizzi A; Anzivino E; Iannetta M; Zingaropoli MA; Rodio DM; Morreale M; Pontecorvo S; Francia A; Vullo V; Palamara AT; Ciardi MR
J Neurovirol; 2015 Dec; 21(6):653-65. PubMed ID: 25930159
[TBL] [Abstract][Full Text] [Related]
20. New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy.
Bellizzi A; Anzivino E; Rodio DM; Palamara AT; Nencioni L; Pietropaolo V
Clin Dev Immunol; 2013; 2013():839719. PubMed ID: 23690827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]